1 Min Read
June 7 (Reuters) - Revive Therapeutics Ltd
* Revive therapeutics announces positive results from its research program of cannabinoid-based therapies targeting liver diseases Source text for Eikon: Further company coverage:
All quotes delayed a minimum of 15 minutes. See here for a complete list of exchanges and delays.
© 2018 Reuters. All Rights Reserved.